Market Tracker

12/19 6:05pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

9.15
Data as of Dec 19
 +0.285 / +3.21%
Today’s Change
5.92
Today|||52-Week Range
22.57
-50.00%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close8.87
Today’s open8.81
Day’s range8.71 - 9.50
Volume2,139,438
Average volume (3 months)1,106,201
Market cap$222.1M
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-4.26%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...-0.41-2.56%
OHRPOHR Pharmaceutical I...+0.04+0.46%
CARACara Therapeutics In...+0.10+1.01%
CNCEConcert Pharmaceutic...+0.72+6.00%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts